Cooper Exceeds Morgan Keegan's Estimates, New PT

Morgan Keegan has published a research report on Cooper Companies, Inc. COO after the company's 4Q results exceeded expectations. In the report, Morgan Keegan writes "Cooper reported 4Q results that significantly exceed our and consensus estimates. Sales were $313 mn (MK $299 mn, Street $298 mn) and EPS was $1.09, $0.21 ahead of our estimate. In our opinion, management delivered a very strong quarter reflecting market share gains, expansion in operating margin and robust FCF generation, all of which are central to our positive thesis. Moreover, management provided 2011 guidance that was above consensus, with sales of $1.25-$1.28 bn (consensus $1.21 bn) and EPS guidance of $3.30-$3.50 (consensus $3.23). Importantly, we believe that there could be upside to operating margin guidance." Morgan Keegan maintains its Outperform rating and has raised the price target from $55 to $64. Cooper Companies, Inc. closed yesterday at $53.56.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsCooper CompaniesHealth CareHealth Care SuppliesMorgan Keegan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!